RE:InterestingARIMA11, Interesting how?
"We are excited about reaching this important milestone, which is a testament of the hard work that all our investigators, GOG leadership, team members and collaborators has put in, and are grateful to the patients that have participated in the study," said Dr. Sunil Gupta MBBS, FRCPC, Chief Medical Officer of OncoQuest Pharma US, Inc. (a subsidiary of CanariaBio Inc.) "We remain on track with our projected enrollment, and we are excited about the potential benefits that our drug may bring to patients with ovarian cancer."
How does OncoQuest Pharma US, Inc. fit in with OncoQuest Pharmaceuticals, Inc. ("OQP")
This is getting more and more confusing! You would think that QPT's CEO would issue a news update to clarify this web of confusion.
Who really owns " Oregovomab "?
G1945V